Leavy spent 20 years in asset management, including senior roles with heavy hitters like Morgan Stanley, Oppenheimer Funds and BlackRock, where he oversaw $115 billion in equity funds. Barron’s named him a “Top 100 Fund Manager.” Leavy retired in his early forties – but cut short his retirement to join Los Angeles-based MedMen in the spring of 2017. Since then, Leavy has led the company’s investment and acquisition efforts, applying the same strategies – buying undervalued assets in high-barrier markets – that earned him Wall Street kudos. Last year saw MedMen’s acquisition of Bloomfield Industries – a financially strapped New York MMJ business – and the closing of a $60 million fund to new investors. To round out a busy year, MedMen set the daunting goal of raising $250 million for a new investment fund, a record sum for the cannabis industry. Because of Leavy’s pedigree, MedMen’s sometimes-brash style and the firm having to close its first fund before it hit its $100 million target, Leavy and MedMen are on industry observers’ radars.